产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | A549/Tax (人肺腺癌紫杉醇耐药性细胞) (STR鉴定正确) |
| 种属 | 人 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 上皮细胞样 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养方案A（默认） |
生长培养基:
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 1:2-1:3 |
| 推荐换液频率 | 2-3次/周 |
| 注意事项 | 耐药株生长速度慢，1:2传代一周左右可以再次传代，细胞形态比较梭长。当细胞生长速度过慢时，可以采用以下方式进行扩增培养：用含低浓度药物的培养基连续培养2周，期间根据细胞密度，需要传代时，传代处理。待细胞状态恢复后，提高培养基中药物的浓度进行培养，此时梯度加药，每个浓度培养一个代次（即持续培养到长满传代，即换下一个浓度），之后细胞状态没有问题的话，持续用加药培养基进行培养即可。 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 肺癌细胞 |
STR鉴定
-
STR位点信息
Amelogenin X,Y CSF1PO 10,12 D2S1338 24 D3S1358 16 D5S818 11 D7S820 8,11 D8S1179 13,14 D13S317 11 D16S539 11,12 D18S51 14,17 D19S433 13 D21S11 29 FGA 23 PentaD 9 PentaE 7,11 TH01 8,9.3 TPOX 8,11 vWA 14 D6S1043 11,13 D12S391 18 D2S441 10,13 -
STR鉴定图
-
参考文献
-
Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy (2024-01-06)
作者：Haobing Wang:1.College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China. ; Yidan Lai:1.College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China. ; 2.School of Pharmaceutical Science, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. ; Dan Li:1.College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China. ; Johannes Karges:1.Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Bochum 44780, Germany. ; Pingyu Zhang:1.College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China. ; Huaiyi Huang:1.School of Pharmaceutical Science, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. ;
期刊：Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy
DOI：10.1021/acs.jmedchem.3c01889
影响因子 ：7.3
引用产品： A549 [A-549] 细胞 , A549/DDP 细胞 , A549/Tax 细胞 , A-431 细胞 , MRC-5 细胞
-
Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance (2022-11-11)
作者：Changduo Wang:1.Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. ; Zhipeng Li:1.Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. ; Ping Xu:1.Department of Thoracic Surgery, the Second Affiliated Hospital of Qingdao University, Qingdao, 266000, China. ; Lisa Xu:1.School of Public Health, Qingdao University, Qingdao, 266071, China. ; Shangcong Han:1.Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. ; Yong Sun:1.Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. sunyong@qdu.edu.cn. ;
期刊：Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance
DOI：10.1186/s12951-022-01689-y
影响因子 ：9.4
引用产品： A549 [A-549] 细胞 , A549/Tax 细胞
-
Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation (2009-01-20)
作者：Tingting Zou:1.School of Life Sciences, Chongqing University, Chongqing 401331, China. ; Cheng Zeng:1.School of Life Sciences, Chongqing University, Chongqing 401331, China. ; Junyan Qu:1.School of Life Sciences, Chongqing University, Chongqing 401331, China. ; Xiaohua Yan:1.Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China. ; Zhenghong Lin:1.School of Life Sciences, Chongqing University, Chongqing 401331, China. ;
期刊：Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation
DOI：10.3390/biomedicines9091143
影响因子 ：4.7
引用产品： MCF-7/ADM 细胞 , MCF7 [MCF-7] 细胞 , A549 [A-549] 细胞 , A549/Tax 细胞
-
RNA editing enzyme adenosine deaminases acting on RNA 1 deficiency increases the sensitivity of non-small cell lung cancer cells to anlotinib by regulating CX3CR1-fractalkine expression (2007-01-20)
作者：Min Wu:1.Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China. ; Mengmeng Jin:1.Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China. ; Xiaohui Cao:1.Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China. ; Kun Qian:1.Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China. ; Lei Zhao:1.Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China. ;
期刊：RNA editing enzyme adenosine deaminases acting on RNA 1 deficiency increases the sensitivity of non-small cell lung cancer cells to anlotinib by regulating CX3CR1-fractalkine expression
影响因子 ：3.8
引用产品： NCI-H1975 细胞 , A549/Tax 细胞 , 青霉素-链霉素-两性霉素B溶液 (100×)
-
Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation (2003-00-20)
作者：Yanna Zhao:1.Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China. ; Chang Cai:1.Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China. ; Min Liu:1.Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China. Electronic address: liumin_panpan@163.com. ; Yuping Zhao:1.Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China. ; Yushu Wu:1.Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China. ; Zhiping Fan:1.Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China. ; Zhuang Ding:1.Institute of Biopharmaceutical Research, Liaocheng University, Hu
期刊：Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation
DOI：10.1016/j.ijbiomac.2020.03.060
影响因子 ：8.2
引用产品： Ham's F-12K 培养基 , A549 [A-549] 细胞 , A549/Tax 细胞
-
Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel (2008-00-20)
作者：Yonghong Wang:1.College of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, PR China; Shandong Engineering Research Center for Smart Materials and Regenerative Medicine, Weifang Medical University, Weifang 261053, Shandong, PR China. ; Hongli Yu:1.College of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, PR China. ; Saisai Wang:1.College of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, PR China. ; Chengcheng Gai:1.Department of Pathology, Weifang Medical University, Weifang 261053, Shandong, PR China. ; Xiaoming Cui:1.College of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, PR China. ; Zhilu Xu:1.College of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, PR China. ; Wentong Li:1.Shandong Engineering Research Center for Smart Materials and Regenerative Medicine, Weifang Medical University, Weifang 261053, Shandong, PR China; Department of Pathology, Weifang Medical University, Weifang 261053, Shand
期刊：Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel
DOI：10.1016/j.msec.2020.111442
影响因子 ：1.9
引用产品： A549 [A-549] 细胞 , A549/Tax 细胞
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
![293 [HEK-293] (人胚肾细胞) (STR鉴定正确)](/Public/upfile/pic/xbx/CL-0001-1-1.jpg)
